For the 30 percent of clinically depressed people who don’t respond to medication, the U.S. Food and Drug Administration recently approved a new, noninvasive treatment option. With NeuroStar TMS, a wand held over the head delivers highly focused magnetic pulses to a part of the brain that’s been linked to depression. A typical course of treatment would involve 40-minute sessions at a psychiatrist’s office five times a week for four to six weeks. In two clinical trials, roughly half of patients said that their symptoms were reduced by at least 50 percent.
Courtesy of Neuronetics
Product: NeuroStar TMS Therapy system
Cost: Approximately $6,000 for a course of 20 to 30 sessions, depending on the provider
Other products in this section:
Technology is changing faster than ever before.
At EmTech MIT, hear experts’ opinions on the future of their industries.
US scientist who edited human embryos with CRISPR responds to critics
Can we safely fix the DNA of human embryos in a lab dish?
Data-mining medieval text reveals medically bioactive ingredients
Medieval apothecaries used recipes with significant antibacterial properties, researchers say.
Million-person genetic study finds gene patterns linked to how long people stay in school
Researchers explore genetic “scores” that may predict educational success.